Delivery Order SPE2DB20D1004-SPE2DB25FNFSQ

Award Date 3/19/25
Potential Completion Date 3/20/25
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $19,410.24 firm-fixed-price contract is for the supply of ENBREL 50 MG/ML SURECLICK, a specialty medication. The delivery order has an ultimate completion date of October 2, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $51,462.68 firm fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of ENBREL 50 MG/ML SURECLICK syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has a completion date...
This federal contract award from the Defense Logistics Agency (DLA) is a $11,489.44 firm fixed-price delivery order placed with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ENBREL 50 MG/ML SURECLICK ML. The contract has an ultimate completion date of April 21, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract, valued at $57,321.41, to Amerisourcebergen Drug Corporation's Corporate Office division. This contract is for the supply of ENBREL 50 MG/ML syringes, with an ultimate completion date of April 22, 2024. The contract is a Firm Fixed Price arrangement, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $17,382.36 to AmerisourceBergen Drug Corp for the supply of ENBREL 50 MG/ML SURECLICKML pharmaceutical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical and medical supplies to support military healthcare...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $9,314.26 firm-fixed-price delivery order contract (SPE2DB22D1017|SPE2DB24FG2FJ) for ENBREL 50 MG/ML SURECLICKML. The contract has an ultimate completion date of July 31, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies to supply a wide range of pharmaceutical and medical products, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,509.28, is a Delivery Order for the supply of ENBREL 50 MG/ML SURECLICKML pharmaceutical product. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $60,722.71 firm fixed-price delivery order is for the supply of ENBREL 50 MG/ML SURECLICK medication. The contract has an ultimate completion date of May 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,878.60 firm fixed-price delivery order is for the supply of ENBREL 50 MG/ML SURECLICK, a specialty pharmaceutical product. The contract has an ultimate completion date of June 7, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a $64,067.45 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, the Corporate Office division of parent company Cencora, Inc. The contract is for the supply of 4,564,296,637 units of the pharmaceutical product ENBREL 50 MG/ML SURECLICKML. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNFSQ
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,626.77 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SURECLICKML. This contract has an ultimate completion date of March 20, 2025 and was not set aside for any specific business category.

AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 6/18/25, 11:35 AM